[go: up one dir, main page]

YU2494A - Farmaceutska formulacija za tretiranje zavisnosti od nikotina - Google Patents

Farmaceutska formulacija za tretiranje zavisnosti od nikotina

Info

Publication number
YU2494A
YU2494A YU2494A YU2494A YU2494A YU 2494 A YU2494 A YU 2494A YU 2494 A YU2494 A YU 2494A YU 2494 A YU2494 A YU 2494A YU 2494 A YU2494 A YU 2494A
Authority
YU
Yugoslavia
Prior art keywords
pct
treatment
pharmaceutical formulation
sec
date
Prior art date
Application number
YU2494A
Other languages
English (en)
Other versions
YU48559B (sh
Inventor
J.A. Moorman
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh. & Co. Kg.
Hf Arzneimitt4Elforschung Gmbh. & Co. Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh. & Co. Kg., Hf Arzneimitt4Elforschung Gmbh. & Co. Kg. filed Critical Lts Lohmann Therapie-Systeme Gmbh. & Co. Kg.
Publication of YU2494A publication Critical patent/YU2494A/sh
Publication of YU48559B publication Critical patent/YU48559B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pronalazak se odnosi na upotrebu galantamina kao i njegovih farmaceutski prihvatljivih adicionih soli sa kiselinama za tretiranje zavisnosti od nikouna. Aktivne supstance se oslobađaju iz farmaceutskih formulacija, na pr. oralno, transdermalno ili različito parenteralno na kontinualan i kontrolisan način.
YU2494A 1993-01-23 1994-01-21 Farmaceutska formulacija za tretiranje zavisnosti od nikotina YU48559B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4301782A DE4301782C1 (de) 1993-01-23 1993-01-23 Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit

Publications (2)

Publication Number Publication Date
YU2494A true YU2494A (sh) 1997-01-08
YU48559B YU48559B (sh) 1998-11-05

Family

ID=6478780

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2494A YU48559B (sh) 1993-01-23 1994-01-21 Farmaceutska formulacija za tretiranje zavisnosti od nikotina

Country Status (23)

Country Link
US (1) US5643905A (sh)
EP (1) EP0680326B1 (sh)
JP (1) JP3511074B2 (sh)
KR (1) KR100301547B1 (sh)
AT (1) ATE146677T1 (sh)
AU (1) AU685075B2 (sh)
CZ (1) CZ284605B6 (sh)
DE (2) DE4301782C1 (sh)
DK (1) DK0680326T3 (sh)
ES (1) ES2098920T3 (sh)
GR (1) GR3022862T3 (sh)
HR (1) HRP940029B1 (sh)
HU (1) HU221159B1 (sh)
IL (1) IL108234A (sh)
MY (1) MY111260A (sh)
NO (1) NO306894B1 (sh)
NZ (1) NZ259858A (sh)
PL (1) PL174812B1 (sh)
SI (1) SI9400028A (sh)
SK (1) SK282247B6 (sh)
WO (1) WO1994016708A1 (sh)
YU (1) YU48559B (sh)
ZA (1) ZA94413B (sh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19509663A1 (de) 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
AT402691B (de) * 1996-01-26 1997-07-25 Sanochemia Ltd Verwendung von galanthamin zum herstellen von arzneimitteln zur behandlung von trisomie 21 oder verwandter trisomie-syndrome
US6218383B1 (en) * 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
EP1133230A4 (en) * 1998-11-23 2004-05-26 Bonnie M Davis DOSAGE FORMULAS FOR ACETYLCHOLINESTERASE INHIBITORS
ID29021A (id) * 1998-12-24 2001-07-26 Janssen Pharmaceutica Nv Komposisi galantamina pelepasan terkontrol
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
MXPA02005667A (es) * 1999-12-10 2004-09-10 Bonnie Davis Analogos de galantamina y licoramina como moduladores de los receptores nicotinicos.
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
DE10119862A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Galanthamin zur Behandlung von Krankheitserscheinungen des zentralen Nervensystems aufgrund von Intoxikationen mit psychotropen Substanzen
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10235556A1 (de) * 2002-08-03 2004-02-19 Hf Arzneimittelforschung Gmbh Medikament und Verfahren zur Verringerung des Alkohol- und/oder Tabakkonsums
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
WO2004075916A1 (en) 2003-02-27 2004-09-10 Shirankai Kyoto University Faculty Of Medicine Alumni Association Inc. Pharmaceutical composition for treatment of drug dependence
BG65658B1 (bg) * 2003-11-13 2009-05-29 "Софарма" Ад Комбиниран лекарствен продукт на основата на галантамин
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine
US20050142193A1 (en) * 2003-12-31 2005-06-30 Lijuan Tang Galantamine formulations
WO2005115471A2 (en) * 2004-05-27 2005-12-08 Neurocure Ltd. Methods and compositions for treatment of nicotine dependence and dementias
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
JP2013523092A (ja) 2010-03-26 2013-06-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 非喫煙用タバコ製品の消費中の感覚刺激の抑制
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
CN101829068A (zh) * 2010-05-06 2010-09-15 徐州市光合生物营养品有限公司 一种水溶性药物缓释片及其制备方法
BG66818B1 (bg) 2013-03-07 2019-01-31 Berbee Beheer B. V. Състав на екстракт от hippeastrum papilio за производство на лекарствени средства и хранителни добавки
US10335378B2 (en) 2013-03-15 2019-07-02 Altria Client Services Llc Inhibition of central nervous system effects from smoking and sensory effects from smoking
BG67408B1 (bg) 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4597961A (en) * 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3843239C1 (sh) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
DE4010079A1 (de) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
WO1992020327A1 (en) * 1991-05-14 1992-11-26 Ernir Snorrason Treatment of fatigue syndrome with cholinesterase inhibitors
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans

Also Published As

Publication number Publication date
GR3022862T3 (en) 1997-06-30
WO1994016708A1 (de) 1994-08-04
SK89095A3 (en) 1996-05-08
JPH08505633A (ja) 1996-06-18
SI9400028A (en) 1994-09-30
KR960700061A (ko) 1996-01-19
PL309604A1 (en) 1995-10-30
NO952906D0 (no) 1995-07-21
ES2098920T3 (es) 1997-05-01
EP0680326B1 (de) 1996-12-27
HU221159B1 (en) 2002-08-28
YU48559B (sh) 1998-11-05
IL108234A (en) 1996-10-31
DE59401401D1 (de) 1997-02-06
NZ259858A (en) 1997-03-24
SK282247B6 (sk) 2001-12-03
KR100301547B1 (ko) 2001-10-22
ZA94413B (en) 1994-09-09
HUT72670A (en) 1996-05-28
AU685075B2 (en) 1998-01-15
CZ184395A3 (en) 1996-02-14
NO306894B1 (no) 2000-01-10
NO952906L (no) 1995-07-21
ATE146677T1 (de) 1997-01-15
US5643905A (en) 1997-07-01
HRP940029A2 (en) 1997-06-30
JP3511074B2 (ja) 2004-03-29
DE4301782C1 (de) 1994-08-25
HRP940029B1 (en) 2000-06-30
AU5881894A (en) 1994-08-15
IL108234A0 (en) 1994-04-12
EP0680326A1 (de) 1995-11-08
PL174812B1 (pl) 1998-09-30
HU9501964D0 (en) 1995-09-28
DK0680326T3 (da) 1997-06-23
MY111260A (en) 1999-10-30
CZ284605B6 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
ATE195249T1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
CZ176595A3 (en) The application of anticonvulsive agents for the preparation of medicaments intended for treating parkinson's disease and parkinson's syndromes
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
BG102689A (bg) Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
BR9407748A (pt) Formulação farmacéutica processo para preparação da mesma e processo para a prevenção e/ou o tratamento de neurodegeneração ou para a obtenção de um efeito anti-convulsivo ou sedação em um paciente
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
MY124465A (en) Reduction of infarct volume using citicoline
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
ATE143947T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
GEP20043377B (en) Pharmaceutical Complex
NO950177L (no) Farmakologisk aktive erivater
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
IL140839A0 (en) Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis